Building Cross-Tissue Fibrosis Atlases to Identify Conserved Pathogenic Cell States & New Therapeutic Targets

11:00 am - Wednesday 2nd December 2026

  • Integrating single-cell and spatial datasets across lung, liver, kidney, joint, gut, skin, and other fibrotic tissues 
  • Identifying conserved macrophage states that persist across organs to distinguish truly pan-fibrotic mechanisms from tissue-specific biology 
  • Using cross-tissue atlases to prioritize targets, select the most relevant disease indications, and match mechanisms with fit-for-purpose translational models

Speakers:

Senior Principal Scientist
Pfizer